Melt Pharmaceuticals, Inc. Contracts & Agreements
19 Contracts & Agreements
- Business Finance (6 contracts)
- Business Operations (2)
- Human Resources (5)
- Uncategorized (6)
- Asset Purchase Agreement, dated December 11, 2018, by and between the Registrant and Imprimis Pharmaceuticals, Inc (Filed With SEC on September 21, 2022)
- Registrants 2018 Equity Incentive Plan (Filed With SEC on September 21, 2022)
- Form of Stock Option Grant Notice and Option Agreement under 2018 Equity Incentive Plan (Filed With SEC on September 21, 2022)
- Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under 2018 Equity Incentive Plan (Filed With SEC on September 21, 2022)
- Form of Non-Employee Director Deferred Issuance Restricted Stock Unit Grant Notice and Non-Employee Director Deferred Issuance Restricted Stock Unit Award Agreement under 2018... (Filed With SEC on September 21, 2022)
- Form of Non-Employee Director and Officer Restricted Stock Unit Grant Notice and Non-Employee Director and Officer Restricted Stock Unit Award Agreement under 2018 Equity... (Filed With SEC on September 21, 2022)
- Loan and Security Agreement, dated September 1, 2021, by and between the Registrant and Harrow Health, Inc (Filed With SEC on September 21, 2022)
- Amendment to Loan and Security Agreement, dated April 8, 2022, by and between the Registrant and Harrow Health, Inc (Filed With SEC on September 21, 2022)
- Patent Security Agreement, dated September 1, 2021, by and between the Registrant and Harrow Health, Inc (Filed With SEC on September 21, 2022)
- Trademark Security Agreement, dated September 1, 2021, by and between the Registrant and Harrow Health, Inc (Filed With SEC on September 21, 2022)
- Right of First Refusal Agreement, dated September 1, 2021, by and between the Registrant and Harrow Health, Inc (Filed With SEC on September 21, 2022)
- Management Services Agreement, dated February 1, 2019, by and between the Registrant an Harrow Health, Inc (Filed With SEC on September 21, 2022)
- Royalty Agreement, dated October 3, 2019, by and between the Registrant and OHSO, LLC (Filed With SEC on September 21, 2022)
- Offer Letter, dated June 18, 2021, by and between the Registrant and Larry Dillaha, M.D (Filed With SEC on September 21, 2022)
- Offer Letter, dated September 27, 2018, by and between the Registrant and Gregory Madison (Filed With SEC on September 21, 2022)
- Offer Letter, dated April 29, 2019, by and between the Registrant and Mark Hazard (Filed With SEC on September 21, 2022)
- Offer Letter, dated February 18, 2022, by and between the Registrant and D. Bradford Osborne (Filed With SEC on September 21, 2022)
- Letter of Termination and Release Agreement, dated May 28, 2021, by and between the Registrant and Mark Hazard (Filed With SEC on September 21, 2022)
- Second Amendment to Loan and Security Agreement, dated September 21, 2022, by and between the Registrant and Harrow Health, Inc (Filed With SEC on September 21, 2022)
